Aspiriant, LLC Amgen Inc Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aspiriant, LLC holds 4,438 shares of AMGN stock, worth $1.31 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,438

Previous 4,443 0.11%

Holding current value

$1.31 Million

Previous $1.39 Million 2.95%

% of portfolio

0.05%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$309.38 - $337.38 $1,546 - $1,686	-5 Reduced 0.11%	4,438 $1.43 Million
Q2 2024 Jul 15, 2024	SELL	$262.75 - $319.31 $131,375 - $159,655	-500 Reduced 10.12%	4,443 $1.39 Million
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $1,075 - $1,298	-4 Reduced 0.08%	4,943 $1.41 Million
Q4 2023 Jan 26, 2024	SELL	$255.7 - $288.46 $13,552 - $15,288	-53 Reduced 1.06%	4,947 $1.42 Million
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $52,913 - $65,693	242 Added 5.09%	5,000 $1.34 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $179,986 - $212,830	840 Added 21.44%	4,758 $1.06 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $64,350 - $78,432	285 Added 7.84%	3,918 $947,000
Q4 2022 Jan 23, 2023	BUY	$229.03 - $291.01 $37,102 - $47,143	162 Added 4.67%	3,633 $0
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $36,362 - $41,010	162 Added 4.9%	3,471 $783,000
Q2 2022 Jul 25, 2022	BUY	$230.71 - $256.74 $5,537 - $6,161	24 Added 0.73%	3,309 $806,000
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $70,604 - $78,107	-322 Reduced 8.93%	3,285 $797,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $95,064 - $108,792	478 Added 15.28%	3,607 $810,000
Q3 2021 Oct 27, 2021	BUY	$212.27 - $248.7 $5,943 - $6,963	28 Added 0.9%	3,129 $665,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $19,153 - $21,249	82 Added 2.72%	3,101 $757,000
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $213,921 - $249,290	964 Added 46.91%	3,019 $752,000
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $9,087 - $10,822	42 Added 2.09%	2,055 $473,000
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $1,642 - $1,826	7 Added 0.35%	2,013 $509,000
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $162,204 - $199,046	-820 Reduced 29.02%	2,006 $473,000
Q1 2020 May 05, 2020	BUY	$182.24 - $241.7 $16,583 - $21,994	91 Added 3.33%	2,826 $570,000
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $78,175 - $93,670	-449 Reduced 14.1%	2,735 $532,000
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $277,635 - $312,955	-1,535 Reduced 32.53%	3,184 $606,000
Q4 2018 Feb 04, 2019	SELL	$178.4 - $208.25 $10,525 - $12,286	-59 Reduced 1.23%	4,719 $919,000
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $22,420 - $25,275	-121 Reduced 2.47%	4,778 $991,000
Q2 2018 Aug 07, 2018	BUY	$166.05 - $186.51 $91,659 - $102,953	552 Added 12.7%	4,899 $904,000
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $456,274 - $533,214	2,693 Added 162.82%	4,347 $741,000
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $449,150 - $501,837	-2,661 Reduced 61.67%	1,654 $288,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $721,856 - $824,165	4,315	4,315 $805,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account